Hosted on MSN2mon
Study unveils 13 genes that increase the risk of osteoarthritisBut for a new therapy to be developed ... they can provide new insights into an array of biological processes that may be contributing to osteoarthritis. "Some of these genes have known roles ...
Aggressive treatment of arthritis often involves using one or ... and ankylosing spondylitis, biologic response modifiers (biologics) work by altering the function of the immune system that ...
Korea: A recent retrospective cohort study published in the Journal of the American Academy of Dermatology explored the link ...
Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...
ALLAN GIBOFSKY: In rheumatoid arthritis, a person's immune system ... With RA, your immune system is in overdrive. Biologic therapies are genetically engineered proteins-- hence, the term ...
The frequency of injections or infusions needed will vary depending on the particular biologic therapy. You may receive an infusion every few months, or you may require multiple starter injections ...
The topic of biologic therapy for IBD has been selected for ... of efficacy in patients with Crohn's disease and rheumatoid arthritis, and yet, etanercept, a TNF receptor antagonist that is ...
Project leader and principal investigator Stephanie Bryant (chemical and biological engineering ... our goal is to develop a suite of non-invasive therapies that can end osteoarthritis,” Bryant said ...
Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results